Some assays link the PEDF molecule to mechanisms that suppress breast cancer metastasis by regulating the epithelial–mesenchymal transition [66,67,68,69]; others report surprising observations, such as that PEDF constitutively activates p42/44 MAPK/Erk but paradoxically does not affect mitogenic signaling [70]. Here, SERPINF1 is linked to breast carcinoma.